<VariationArchive VariationID="1308632" VariationName="NM_001375380.1(EBF3):c.239dup (p.Pro81fs)" VariationType="Duplication" Accession="VCV001308632" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2021-11-06" MostRecentSubmission="2021-11-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1298901" VariationID="1308632">
      <GeneList>
        <Gene Symbol="EBF3" FullName="EBF transcription factor 3" GeneID="253738" HGNC_ID="HGNC:19087" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="129835233" stop="129964274" display_start="129835233" display_stop="129964274" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="131633495" stop="131762090" display_start="131633495" display_stop="131762090" Strand="-" />
          </Location>
          <OMIM>607407</OMIM>
          <Haploinsufficiency last_evaluated="2023-12-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EBF3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-12-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EBF3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001375380.1(EBF3):c.239dup (p.Pro81fs)</Name>
      <CanonicalSPDI>NC_000010.11:129963418:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>10q26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="129963418" stop="129963419" display_start="129963418" display_stop="129963419" variantLength="1" positionVCF="129963418" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="131761682" stop="131761683" display_start="131761682" display_stop="131761683" variantLength="1" positionVCF="131761682" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>P81fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.131761683dup" Assembly="GRCh37">
            <Expression>NC_000010.10:g.131761683dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.129963419dup" Assembly="GRCh38">
            <Expression>NC_000010.11:g.129963419dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_030038.1" sequenceAccession="NG_030038" sequenceVersion="1" change="g.5409dup">
            <Expression>NG_030038.1:g.5409dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001005463.3" sequenceAccession="NM_001005463" sequenceVersion="3" change="c.239dup">
            <Expression>NM_001005463.3:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001005463.1" sequenceAccession="NP_001005463" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001005463.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375379.1" sequenceAccession="NM_001375379" sequenceVersion="1" change="c.239dup">
            <Expression>NM_001375379.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362308.1" sequenceAccession="NP_001362308" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362308.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375380.1" sequenceAccession="NM_001375380" sequenceVersion="1" change="c.239dup" MANESelect="true">
            <Expression>NM_001375380.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362309.1" sequenceAccession="NP_001362309" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362309.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375389.1" sequenceAccession="NM_001375389" sequenceVersion="1" change="c.239dup">
            <Expression>NM_001375389.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362318.1" sequenceAccession="NP_001362318" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362318.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375390.1" sequenceAccession="NM_001375390" sequenceVersion="1" change="c.239dup">
            <Expression>NM_001375390.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362319.1" sequenceAccession="NP_001362319" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362319.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375391.1" sequenceAccession="NM_001375391" sequenceVersion="1" change="c.239dup">
            <Expression>NM_001375391.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362320.1" sequenceAccession="NP_001362320" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362320.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375392.1" sequenceAccession="NM_001375392" sequenceVersion="1" change="c.239dup">
            <Expression>NM_001375392.1:c.239dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362321.1" sequenceAccession="NP_001362321" sequenceVersion="1" change="p.Pro81fs">
            <Expression>NP_001362321.1:p.Pro81fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2134659091" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001375380.1(EBF3):c.239dup (p.Pro81fs) AND Hypotonia, ataxia, and delayed development syndrome" Accession="RCV001754540" Version="2">
        <ClassifiedConditionList TraitSetID="34985">
          <ClassifiedCondition DB="MedGen" ID="C4310618">Hypotonia, ataxia, and delayed development syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-06" MostRecentSubmission="2021-11-06">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="34985" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36858" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypotonia, ataxia, and delayed development syndrome</ElementValue>
                <XRef ID="MONDO:0015021" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HADDS</ElementValue>
                <XRef Type="MIM" ID="617330" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">EBF3 neurodevelopmental disorder (EBF3-NDD) is associated with developmental delay (DD) / intellectual disability (ID), speech delay, gait or truncal ataxia, hypotonia, behavioral problems, and facial dysmorphism. Variability between individuals with EBF3-NDD is significant. Although all affected children have DD noted in early infancy, intellect generally ranges from mild to severe ID, with two individuals functioning in the low normal range. Less common issues can include genitourinary abnormalities and gastrointestinal and/or musculoskeletal involvement. To date, 42 symptomatic individuals from 39 families have been reported.</Attribute>
                <XRef ID="NBK570204" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33956416</ID>
                <ID Source="BookShelf">NBK570204</ID>
              </Citation>
              <XRef ID="658843" DB="Orphanet" />
              <XRef ID="C4310618" DB="MedGen" />
              <XRef ID="MONDO:0015021" DB="MONDO" />
              <XRef Type="MIM" ID="617330" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3891604" SubmissionDate="2021-10-29" DateLastUpdated="2021-11-06" DateCreated="2021-11-06">
        <ClinVarSubmissionID localKey="PED8914.1|OMIM:617330" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001994765" DateUpdated="2021-11-06" DateCreated="2021-11-06" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, UniversitÃ© de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EBF3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001005463.2:c.239dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="617330" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10589802</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3891604" TraitType="Disease" MappingType="XRef" MappingValue="617330" MappingRef="OMIM">
        <MedGen CUI="C4310618" Name="Hypotonia, ataxia, and delayed development syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

